Academic arrow_drop_down

Academic Affairs Board


Chair: Prof Phil Kalra

Since 2007, the Association has had an Academic Affairs and a Clinical Affairs Board, each chaired by one of the two vice presidents. The Academic Affairs Board oversees Education, Research and Training matters and is comprised of the chairs of various committees and several elected/co-opted members.

Academic Affairs Board membership

Meetings & Reporting

The Chair will convene at least two meetings a year of the Academic Affairs Board, each meeting to be held at least one month before a meeting of the Executive Committee.

The Chair will provide a written report to the Executive Committee and will lead discussion at the Executive Committee on this report.

Terms of reference

The Academic Affairs Board will concern itself with all aspects of local and national policy and activity relevant to training, education and research in renal medicine and renal science.

By integrating and co-ordinating the work of the committees represented on the Board, the goal will be to strengthen the contribution of the Renal Association to these areas of activity.

The Academic Affairs Board will be actively involved in supporting training education and research involving all constituencies represented within the Association’s membership including consultants, both academic and NHS; clinical trainees; non-consultant career grade clinicians; and renal scientists who are not clinicians.

The Board will in particular:

  • Review and approve the proposals for annual work programmes presented to the Board by the Chair of each Committee.
  • Identify opportunities for complementary work to be undertaken in parallel by the Committees.
  • Identify and manage potential overlap and duplication among the work of its constituent committees.
  • Identify and prioritise training, education and research opportunities, working as appropriate with the Clinical Affairs Board and its committees.
  • Identify opportunities for close working with other bodies active in these areas of work – for example the Kidney Research UK; the Royal Colleges of Physicians of London, Edinburgh & Glasgow; British Renal Society; British Association for Paediatric Nephrology; British Transplantation Society, the UK Kidney Research Consortium.

UK Renal Research Strategy

The UK Kidney Research Consortium held a successful launch event for the UK Renal Research Strategy on April 14th 2016. Find the document here.

Recent Activity

The Board has continued to meet regularly by teleconference and by email circulation.

Board members’ areas are as follows; more information from individual committees can be found in the right hand sidebar.

  • Research Committee (chair Jill Norman) – includes non-clinical scientists’ grouping (see below), important to integrate with clinically-qualified researchers as much as possible. Also the right place to integrate with BRS (their research lead is Paula Ormandy). Also has representation from Renal Scientists Group, Rare Diseases and UKKRC.
  • ‘Basic scientists’ – group aims to look after the interests of a group that historically felt excluded – need to continue to work on this. Current lead is Tim Bowen. Jill Norman is a renal scientist who chairs the Research Committee.
  • International (David Goldsmith) – historically has dealt with visiting fellows from developing countries, aims to attract overseas trainees, and aims to raise the outward-facing profile of the RA, to a wider catchment including in Europe.
    ISN membership is free to UK renal trainees under 37y old.
  • UKKRC (Paula Ormandy) – range of thematic groupings of clinical researchers aiming to develop studies leading to portfolio inclusion. Also includes Dorothea Nitsch’s efforts to train SpRs in epidemiology and trials methodology, and Tom Hiemstra’s Clinical Trials network.
  • Education and Training Committee (Aine Burns)plays a role in postgraduate training, dealing with SAC and the MRCP SCE exam. Academic Training has been more under the umbrella of research committee.
  • Rare Diseases (Detlef Bockenhauer). A growing portfolio of rare disease groups now; RADAR online for all and has signed up nearly 14,000 patients.
  • BAPN – Research committee, Exec and Trustees all have BAPN representation; cross-fertilisation is important wherever possible.